ENORAMA PHARMA ABENORAMA PHARMA ABENORAMA PHARMA AB

ENORAMA PHARMA AB

No trades
See on Supercharts

ERMA fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Enorama Pharma AB engages in the research, development and manufacture of pharmaceutical drug delivery system. It offers medicated chewing gums for people having difficulty swallowing tablets or who may have various problems with digestion. The company was founded by Mats-Olle Rönngard on November 28, 2006 and is headquartered in Malmo, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
ERMA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company